(CHRS) Coherus Biosciences complete technical analysis [charts+indicators] | Buy/Sell Coherus Biosciences | (CHRS) share price targets
Complete technical analysis of Coherus Biosciences (CHRS) by charts plus indicators, forecast predictions and share price targets for Coherus Biosciences (CHRS)
Coherus Biosciences trades in USA in Health Care sector.
10 day averaged volume of Coherus Biosciences is 1876180
| Date | Daily Closing Price | Open | High | Low | Volume |
| 24 Fri Jan 2025 | 1.24 | 1.34 | 1.38 | 1.21 | 1.716 times |
| 23 Thu Jan 2025 | 1.28 | 1.33 | 1.36 | 1.24 | 2.281 times |
| 22 Wed Jan 2025 | 1.31 | 1.35 | 1.45 | 1.29 | 1.541 times |
| 21 Tue Jan 2025 | 1.32 | 1.41 | 1.43 | 1.31 | 1.131 times |
| 17 Fri Jan 2025 | 1.39 | 1.41 | 1.46 | 1.39 | 0.457 times |
| 17 Fri Jan 2025 | 1.39 | 1.41 | 1.46 | 1.39 | 0.457 times |
| 16 Thu Jan 2025 | 1.42 | 1.48 | 1.48 | 1.38 | 0.771 times |
| 15 Wed Jan 2025 | 1.46 | 1.50 | 1.55 | 1.44 | 0.716 times |
| 14 Tue Jan 2025 | 1.44 | 1.47 | 1.60 | 1.44 | 1.254 times |
| 13 Mon Jan 2025 | 1.47 | 1.46 | 1.50 | 1.44 | 0.641 times |
Although my analysis for stock is bearish for shortterm, but stock is in heavy over sold zones and there are high chances of some recovery tomorrow. You might want to buy the stock tomorrow in intra day with a stoploss of 1.2, for a target of 1.3 or 1.44
Share price targets for Coherus Biosciences (CHRS)
| Target Type | Value |
| Downside Target | 0.66 |
| Downside Target | 0.71 |
| Downside Target | 0.97 |
| Downside Target | 1.21 |
| Upside Target | 1.35 |
| Upside Target | 1.38 |
| Upside Target | 1.42 |
| Upside Target | 1.50 |
| Upside Target | 1.60 |
| Upside Target | 1.65 |
| Upside Target | 1.77 |
| Upside Target | 1.85 |
Intraday share price targets for Coherus Biosciences (CHRS)
| Target Type | Value |
| Downside Intraday Target | 1.15 |
| Downside Intraday Target | 1.06 |
| Upside Intraday Target | 1.39 |
| Upside Intraday Target | 1.54 |
| Upside Intraday Target | 1.3 |
Weekly technical analysis of Coherus Biosciences (CHRS)
| Date | Weekly Closing Price | Open | High | Low | Volume |
| 24 Fri Jan 2025 | 1.24 | 1.41 | 1.45 | 1.21 | 14.58 times |
| 17 Fri Jan 2025 | 1.39 | 1.41 | 1.46 | 1.39 | 0.119 times |
| 17 Fri Jan 2025 | 1.39 | 1.46 | 1.60 | 1.38 | 2.781 times |
| 10 Fri Jan 2025 | 1.47 | 1.58 | 1.65 | 1.44 | 0.471 times |
| 08 Wed Jan 2025 | 1.51 | 1.65 | 1.77 | 1.50 | 0.607 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Coherus Biosciences (CHRS)
| Date | Monthly Closing Price | Open | High | Low | Volume |
| 24 Fri Jan 2025 | 1.24 | 1.43 | 1.77 | 1.21 | 0.739 times |
| 31 Tue Dec 2024 | 1.38 | 1.78 | 1.85 | 1.35 | 0.573 times |
| 26 Tue Nov 2024 | 1.28 | 0.75 | 1.39 | 0.66 | 1.295 times |
| 31 Thu Oct 2024 | 0.75 | 1.04 | 1.23 | 0.71 | 1.375 times |
Scroll below to view daily charts
Price has moved down this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Coherus Biosciences (CHRS)
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Coherus Biosciences stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Coherus Biosciences in short term but the sell signal is initial and weak.
Coherus Biosciences Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Coherus Biosciences in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Coherus Biosciences is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.34 and Coherus Biosciences (CHRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Coherus Biosciences (CHRS) stock. Volume based technical analysis of Coherus Biosciences (CHRS) stock is negative.
Coherus Biosciences Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a short to mid term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
Price action analysis of Coherus Biosciences ( (CHRS) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Coherus Biosciences stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Coherus Biosciences in short term but the sell signal is initial and weak.
Coherus Biosciences Stock is trading near its recent LOWS in short term which reflects strong selling momentum. Bears are weakening, and bulls are picking up momentum!
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Coherus Biosciences in short term and SELL signal is strong!
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in negative zone. This is the SELL zone
Although the stock is in the SELL zone, but selling might be slowing down
Stock of Coherus Biosciences is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 1.34 and Coherus Biosciences (CHRS) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Coherus Biosciences (CHRS) stock. Volume based technical analysis of Coherus Biosciences (CHRS) stock is negative.
Coherus Biosciences Stock has given negative returns over a short term period. Returns for a longer term period have been negative.
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.